Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 28,771 shares at $20.30 ($584K) on 2023-08-24, disclosed to the SEC on 2023-08-25.
Open-market sale of $584k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.30 | 14,385 | $292K | 50.0% |
| 2 | $20.30 | 14,385 | $292K | 50.0% |
| 3 | $20.89 | 1 | $21 | 0.0% |
| Total | $20.30 avg | 28,771 | $584K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |